SQI Diagnostics (SQD) Stock Price, News & Analysis

Company Overview

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.02 to C$0.02
• 50-Day Range: C$0.02 to C$0.02
• 52-Week Range: C$0.01 to C$0.18
• Volume: 65,000 shs
• Average Volume: 172,133 shs
• Market Capitalization: C$6.11 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SQD Stock Analysis - Frequently Asked Questions

How have SQD shares performed this year?

SQI Diagnostics' stock was trading at C$0.02 at the start of the year. Since then, SQD shares have increased by 0.0% and is now trading at C$0.02.

How do I buy shares of SQI Diagnostics?

Shares of SQD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of SQI Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SQI Diagnostics investors own include Snowflake (SNOW), Meta Platforms (META), Cloudflare (NET), NVIDIA (NVDA), Royal Bank Of Canada (RY), Tempest Therapeutics (TPST) and Bank of America (BAC).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: Trading
• Current Symbol: CVE:SQD
• CIK: N/A
• Web: sqidiagnostics.com
• Phone: +1-416-6749500
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$19.14 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -74.70%

Debt

• Debt-to-Equity Ratio: 464.33
• Current Ratio: 0.12
• Quick Ratio: 0.40

Sales & Book Value

• Annual Sales: C$3.04 million
• Price / Sales: 2.01
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 8.50
• Book Value: C($0.04) per share
• Price / Book: -0.38

Miscellaneous

• Outstanding Shares: 407,170,000
• Free Float: N/A
• Market Cap: C$6.11 million
• Optionable: Not Optionable
• Beta: -0.21